Akumin Stock Forecast, Price & News

-0.02 (-0.55 %)
(As of 06/23/2021 01:13 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume2,090 shs
Average Volume35,997 shs
Market CapitalizationC$258.29 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AKU News and Ratings via Email

Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter.

About Akumin

Akumin Inc. provides outpatient diagnostic imaging services in the United States. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The company provides various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures; and online medical bill payment services. As of December 31, 2020, the company operated 127 outpatient diagnostic imaging centers located in Florida, Texas, Pennsylvania, Delaware, Georgia, Illinois, and Kansas. Akumin Inc. is headquartered in Plantation, Florida.


Heres what Wall Street expects from Akumins earnings report
Here's what Wall Street expects from Akumin's earnings report
May 15, 2021 |  markets.businessinsider.com
Morning News Call - Canada, March 31
Morning News Call - Canada, March 31
March 31, 2021 |  finance.yahoo.com
Akumin, Inc. to Host Earnings Call
Akumin, Inc. to Host Earnings Call
March 30, 2021 |  finance.yahoo.com
Akumin is about to announce its earnings — heres what to expect
Akumin is about to announce its earnings — here's what to expect
March 30, 2021 |  markets.businessinsider.com
Akumin Inc. (AKU)
Akumin Inc. (AKU)
March 23, 2021 |  finance.yahoo.com
Akumin Enters into Settlement Agreement
Akumin Enters into Settlement Agreement
February 1, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 2.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Akumin (TSE:AKU) Frequently Asked Questions

Is Akumin a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Akumin stock.
View analyst ratings for Akumin
or view top-rated stocks.

What stocks does MarketBeat like better than Akumin?

Wall Street analysts have given Akumin a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Akumin wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Akumin's next earnings date?

Akumin is scheduled to release its next quarterly earnings announcement on Wednesday, August 11th 2021.
View our earnings forecast for Akumin

How were Akumin's earnings last quarter?

Akumin Inc. (TSE:AKU) posted its quarterly earnings data on Wednesday, March, 31st. The company reported $0.04 EPS for the quarter. The firm earned $75.85 million during the quarter.
View Akumin's earnings history

How has Akumin's stock been impacted by Coronavirus?

Akumin's stock was trading at C$4.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AKU stock has decreased by 9.5% and is now trading at C$3.63.
View which stocks have been most impacted by COVID-19

What price target have analysts set for AKU?

2 brokerages have issued 12 month target prices for Akumin's shares. Their forecasts range from C$3.25 to C$5.25. On average, they anticipate Akumin's share price to reach C$4.25 in the next year. This suggests a possible upside of 17.1% from the stock's current price.
View analysts' price targets for Akumin
or view top-rated stocks among Wall Street analysts.

Who are Akumin's key executives?

Akumin's management team includes the following people:
  • Mr. Riadh Zine-El-Abidine, Pres, CEO & Director (Age 49, Pay $1.26M)
  • Mr. Mohammad Saleem, CFO & Corp. Sec.
  • Mr. Rohit Navani, Exec. VP & COO
  • Mr. Matthew Cameron, Sr. VP & Gen. Counsel
  • Mr. Christopher Fitzgerald, Chief Revenue Officer
  • Mr. Kevin G. Johnson, Co-Pres of Advanced Diagnostic Group
  • Ms. Leigh Anne Fernandes, Co-Pres of Advanced Diagnostic Group
  • Darren Speed, Chief Compliance Officer
  • Ms. Lori Marker, VP of HR
  • Ms. Laura Kassa, Sr. VP

Who are some of Akumin's key competitors?

What other stocks do shareholders of Akumin own?

What is Akumin's stock symbol?

Akumin trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AKU."

How do I buy shares of Akumin?

Shares of AKU and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Akumin's stock price today?

One share of AKU stock can currently be purchased for approximately C$3.63.

How much money does Akumin make?

Akumin has a market capitalization of C$258.29 million and generates C$241.84 million in revenue each year.

How many employees does Akumin have?

Akumin employs 1,737 workers across the globe.

What is Akumin's official website?

The official website for Akumin is www.akumin.com.

How can I contact Akumin?

The company can be reached via phone at 416-613-1391.

This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.